CompletedNot Applicable

Comparison of Esomeprazole Versus Vonoprazan in Gastroesophageal Reflux Disease

Pakistan824 participantsStarted 2025-01-01

Plain-language summary

Local literature is deprived of data comparing the effectiveness of esomeprazole and vonoprazan in patients with gastroesophageal reflux disease (GERD). This study was planned with the objective of comparing the effectiveness of esomeprazole versus vonoprazan in patients diagnosed with GERD.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any gender * Aged 18 to 65 years * Presenting with GERD Exclusion Criteria: * Patients with hepatic, renal, respiratory, or cardiac disease accessed on history and medical records. * Any previous history of malignancy accessed from medical records. * Pregnancy and Lactation * Currently using histamine-2 receptor antagonists, antacids, gastrointestinal motility stimulants, and steroids. * History of drug allergy to proton pump Inhibitors (PPIs).

What they're measuring

Sufficient relief

Timeframe: 4 weeks

Trial details

NCT IDNCT07563491

SponsorMuhammad Aamir Latif

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-09-30

View on ClinicalTrials.gov More Gastro Esophageal Reflux trials